Cogent Biosciences Inc

NASDAQ:COGT   3:59:53 PM EDT
8.38
+0.22 (+2.70%)
Other Pre-Announcement

Cogent Biosciences Inc Posts Qtrly Loss Per Share Of $0.43

Published: 08/16/2021 11:34 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Provides Corporate Updates and Reports Second Quarter 2021 Financial Results.
Cogent Biosciences Inc - As of June 30, 2021, Cogent Had Cash and Cash Equivalents of $218.1 Million.
Cogent Biosciences Inc Qtrly Loss per Share $0.43.
Cogent Biosciences - Believes Cash and Cash Equivalents Will Be Sufficient to Fund Its Operating Expenses & Capital Expenditure Requirements Into 2024.